Page last updated: 2024-12-08
n-methacryloyl-5-aminosalicylic acid
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
N-methacryloyl-5-aminosalicylic acid: a dentin primer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 171252 |
SCHEMBL ID | 346822 |
MeSH ID | M0201115 |
Synonyms (15)
Synonym |
---|
n-methacryloyl-5-aminosalicylic acid |
2-hydroxy-5-(2-methylprop-2-enoylamino)benzoic acid |
5-masa |
benzoic acid, 2-hydroxy-5-((2-methyl-1-oxo-2-propenyl)amino)- |
53193-87-6 |
SCHEMBL346822 |
XEYLAWVXYZUVDD-UHFFFAOYSA-N |
5-methacrylamidosalicylic acid |
n-(3-carboxy-4-hydroxyphenyl)methacrylamide |
DTXSID80201250 |
2-hydroxy-5-n-methacrylamidobenzoic acid |
FT-0760675 |
2-hydroxy-5-methacrylamidobenzoic acid |
STARBLD0007128 |
2-hydroxy-5-(2-methylprop-2-enamido)benzoic acid |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (8)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (62.50) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.14
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.14) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 1 (10.00%) | 5.53% |
Reviews | 1 (10.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 8 (80.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |